Explore the groundbreaking discoveries of common and rare genetic variants that influence colorectal cancer risk and how these findings are transforming cancer prevention and treatment.
Discover how an 11-gene signature is revolutionizing colorectal cancer prognosis by predicting recurrence with unprecedented accuracy.
Discover how machine learning and ferroptosis research are revolutionizing colorectal cancer treatment through advanced gene analysis and predictive modeling.
Discover how a groundbreaking 23-gene risk scoring system is transforming personalized treatment for mucinous colorectal cancer patients.
Discover how fecal lactoferrin and immunochemical testing are transforming non-invasive diagnosis of colorectal cancer and ulcerative colitis.
Discover how the transgelin-PARP1 protein interaction drives colorectal cancer metastasis and opens new therapeutic possibilities.
Breakthrough research shows how neratinib and trametinib combo targets aggressive colorectal cancer subtypes regardless of KRAS mutation status